Medical News

RSS

Anacor completes enrollment in AN2728 Phase 2b trial in psoriasis

Anacor Pharmaceuticals announced today that it has completed enrollment in its Phase 2b trial of AN2728, a topical anti-inflammatory product candidate for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disease that affects approximately 7.5 million people in the United States and over 100 million people worldwide.

14 Mar 2011

Surgeons deliver virtual temporal bone dissection course for otolaryngology residents, physicians

Two surgeons from Central Ohio recently traveled to Nicaragua on a humanitarian mission to treat children with serious ear, nose and throat conditions. However, this year they brought along some help in the form of high-tech equipment designed to appeal to a generation that grew up playing video games - not to entertain the children, but to train the local doctors and medical students.

14 Mar 2011

New research: Rhodopsin pigment in Drosophila may detect temperature

New research from Mount Sinai School of Medicine has discovered that rhodopsin, a pigment of the retina that is responsible for the first events in the perception of light, may also be involved in temperature sensation. This detection had not been revealed in previous studies.

14 Mar 2011

EvaluatePharma data shows poor R&D productivity measures both in quality, quantity

Pharmaceutical R&D productivity is consistently undercounted. Most reports fail to fully count the number of new drugs that reach the market, missing out on billions of dollars of sales generated by R&D investment, an analysis of EvaluatePharma data shows.

14 Mar 2011

ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB, has initiated a Phase IIb clinical study of its ChronVac-C DNA vaccine for hepatitis C virus, delivered by Inovio's proprietary electroporation DNA vaccine delivery technology, in combination with standard of care.

14 Mar 2011

Life Technologies receives FDA 510(k) clearance for StemPro MSC SFM device

Life Technologies Corporation today announced it has received FDA 510(k) clearance for StemPro MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the United States.

14 Mar 2011

BioInvent commences BI-204 phase II study in patients with acute coronary syndrome

BioInvent International AB announces today the dosing of the first patient in the phase II study of the Company's antibody, BI-204. The product candidate is being developed for secondary prevention of cardiovascular events in patients with acute coronary syndrome.

14 Mar 2011

UCI's doctor, colleagues earn Kappa Delta Ann Doner Vaughan Award for osteosarcoma work

UC Irvine's Dr. Bang H. Hoang and colleagues have been presented the 2011 Kappa Delta Ann Doner Vaughan Award for their work advancing the understanding of how bone cancer spreads.

14 Mar 2011

Specialists to provide update on latest advancements in surgical field at UCSD conference

The Department of Surgery at the University of California, San Diego School of Medicine will host the 34th San Diego Postgraduate Assembly in Surgery. The event will take place March 17 to 19, 2011 at the Omni San Diego Hotel.

14 Mar 2011

Surgeons use stem cell technology for bone grafts to treat foot, ankle conditions

When patients need a bone graft for a foot or ankle surgery, bone often is taken from another part of their body. Now surgeons are using new methods to get bone material and even stem cells right "off the shelf," according to Glenn M. Weinraub, DPM, FACFAS, a California foot and ankle surgeon who is leading a discussion among surgeons on the next decade of bone healing at the American College of Foot and Ankle Surgeons' Annual Scientific Conference in Fort Lauderdale.

14 Mar 2011

AbCheck licenses CELEXION yeast display technology for an industry first

AbCheck s.r.o., the multi antibody discovery platforms company, announced today the company has licensed a proven antibody yeast display technology from CELEXION LLC (Cambridge, MA, USA). The addition of this platform to AbCheck's current phage display platform places the company as the World's only antibody discovery specialist leveraging the advantage of working with both phage and yeast display technologies.

14 Mar 2011

SOM Biotech closes first financing round and files patent application

SOM Biotech, a biopharmaceutical start-up company with a business model centered on the identification and development of drug repurposing opportunities, reports significant progress on its trajectory towards pipeline development and candidate outlicensing.

14 Mar 2011

SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA

SCOLR Pharma, Inc. today announced it has received a letter from the Food and Drug Administration identifying deficiencies regarding its Abbreviated New Drug Application for extended-release pseudoephedrine.

14 Mar 2011

Pawlenty assails government-run health care in N.H. trip

Likely presidential hopeful Tim Pawlenty urged a roomful of skeptical doctors Friday to be leaders rather than be dragged into what he sees as the future of health care -- giving consumers more information and choices and rewarding providers for quality over volume.

14 Mar 2011

Scientists discover cerebrospinal fluid proteins are essential for brain building

Proteins in fluids bathing the brain are essential for building the brain, discover scientists in a report published March 10 in the journal Neuron. The finding promises to advance research related to neurological disease, cancer and stem cells.

14 Mar 2011

Hospice and Palliative care

The word hospice originated from the Latin hospitium, which means "to host or offer a place of shelter." In 2009, an estimated 1.56 million patients, more than 40 percent of deaths, received hospice services in the United States.

14 Mar 2011

Spaulding Clinical announces 510k approval for ECG device

Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, proudly announces the 510k approval of their proprietary ECG device platform: Spaulding IQ.

14 Mar 2011

GOP's new short-term budget fix does not include health cuts

Buying more time for budget talks, the House Appropriations Committee unveiled a three-week stop-gap bill Friday that will carry the government through April 8 while Republicans and the White House try to hammer out a spending plan for the second half of this fiscal year.

14 Mar 2011

CTI, Chroma enter agreement to co-develop and license tosedostat

Cell Therapeutics, Inc. and Chroma Therapeutics Ltd. announced today that the companies have entered into a co-development and license agreement providing CTI with exclusive marketing and co-development rights to Chroma's drug candidate tosedostat in North, Central and South America.

14 Mar 2011

DaVita enhances company's governance policies and practices

The Board of Directors of DaVita Inc. today announced that it has enhanced the company's already strong corporate governance policies and practices.

14 Mar 2011

Medical News

Anacor completes enrollment in AN2728 Phase 2b trial in psoriasis

Surgeons deliver virtual temporal bone dissection course for otolaryngology residents, physicians

New research: Rhodopsin pigment in Drosophila may detect temperature

EvaluatePharma data shows poor R&D productivity measures both in quality, quantity

ChronTech initiates ChronVac-C DNA vaccine Phase IIb study against HCV

Life Technologies receives FDA 510(k) clearance for StemPro MSC SFM device

BioInvent commences BI-204 phase II study in patients with acute coronary syndrome

UCI's doctor, colleagues earn Kappa Delta Ann Doner Vaughan Award for osteosarcoma work

Specialists to provide update on latest advancements in surgical field at UCSD conference

Surgeons use stem cell technology for bone grafts to treat foot, ankle conditions

AbCheck licenses CELEXION yeast display technology for an industry first

SOM Biotech closes first financing round and files patent application

SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA

Pawlenty assails government-run health care in N.H. trip

Scientists discover cerebrospinal fluid proteins are essential for brain building

Hospice and Palliative care

Spaulding Clinical announces 510k approval for ECG device

GOP's new short-term budget fix does not include health cuts

CTI, Chroma enter agreement to co-develop and license tosedostat

DaVita enhances company's governance policies and practices

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News